GlassScriptPhysician profile
Michael T Mchale
NPI 1508828179
$67,898.38
in general payments reported to CMS, 2019-2025
22 companies · $8,006 in 2025
The $8,006 reported for 2025 was more than what 89% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $5,137 · 2021: $5,320 · 2022: $2,834 · 2023: $9,703 · 2024: $8,880 · 2025: $8,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $4,728 · Travel and Lodging: $522 · Gift: $34.34 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,285.00 |
| Food and Beverage | $4,728.00 |
| Travel and Lodging | $522.27 |
| Gift | $34.34 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $22,052.92 | 2019-2025 | |
| Tesaro, INC. | $19,647.81 | 2019 | |
| Glaxosmithkline, LLC. | $11,246.42 | 2020-2025 | Zejula |
| E.R. Squibb & Sons, L.L.C. | $4,605.99 | 2019 | |
| Intuitive Surgical, INC. | $3,268.92 | 2019-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $2,857.64 | 2019-2025 | Vistaseal, Echelon; Endopath, Stratafix |
| Immunogen, INC. | $2,181.04 | 2023 | |
| Astrazeneca Uk Limited | $1,285.00 | 2020-2024 | Lynparza |
| Merck Sharp & Dohme LLC | $213.46 | 2022-2025 | Keytruda |
| Myriad Genetic Laboratories, INC. | $160.89 | 2021-2023 | Precisetumor |
| Medical Device Business Services, INC. | $102.56 | 2023 | Echelon Flex |
| Genentech USA, INC. | $102.26 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $61.59 | 2022-2024 | |
| Clovis Oncology, INC. | $42.60 | 2019 | |
| Seagen INC. | $25.22 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $22.51 | 2024 | Excelsius3d Imaging System |
| Baxter Healthcare | $21.55 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mchale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.